COR insider trading
NYSE HealthcareCorium International, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.
About Corium International, Inc.
Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; distributes plasma and other blood products, vaccines, and other specialty pharmaceutical products; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; sales force services to manufacturers; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.
Company website: www.cencora.com
COR insider activity at a glance
FilingIQ has scored 1,095 insider transactions for COR since Jan 15, 2015. The most recent filing in our index is dated May 1, 2026.
Across the full history, 4 open-market purchases
and 426 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on COR insider trades is 64.9/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest COR Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
Frequently asked
- How many insider trades does FilingIQ track for COR?
- FilingIQ tracks 1,095 Form 4 insider transactions for COR (Corium International, Inc.), covering filings from Jan 15, 2015 onwards. 27 of those were filed in the last 90 days.
- Are COR insiders net buyers or net sellers?
- Across the full Form 4 history for COR, 4 transactions (0%) were open-market purchases and 426 (39%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does COR insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
- What sector is COR in?
- Corium International, Inc. (COR) is classified in the Healthcare sector, specifically Medical Distribution, with a current market capitalisation of $64.53B.
Methodology & sources
Every COR insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.